AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Suzuma, T Sakurai, T Yoshimura, G Umemura, T Tamaki, T Yoshimasu, T Naito, Y
Citation: T. Suzuma et al., Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma, ANTI-CANC D, 12(9), 2001, pp. 731-734

Authors: Yang, QF Sakurai, T Yoshimura, G Mori, I Nakamura, M Nakamura, Y Suzuma, T Tamaki, T Umemura, T Kakudo, K
Citation: Qf. Yang et al., Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta 2 in breast carcinoma, ANTICANC R, 21(3B), 2001, pp. 1829-1833

Authors: Yang, QF Yoshimura, G Sakurai, T Nakamura, M Nakamura, Y Shan, L Suzuma, T Tamaki, T Umemura, T Mori, I Kakudo, K
Citation: Qf. Yang et al., Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta 2 expression in breast carcinoma, BREAST CANC, 70(1), 2001, pp. 39-45

Authors: Yang, QF Sakurai, T Mori, I Yoshimura, G Nakamura, M Nakamura, Y Suzuma, T Tamaki, T Umemura, T Kakudo, K
Citation: Qf. Yang et al., Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas, CANCER, 92(1), 2001, pp. 54-60

Authors: Yang, QF Mori, I Shan, L Nakamura, M Nakamura, Y Utsunomiya, H Yoshimura, G Suzuma, T Tamaki, T Umemura, T Sakurai, T Kakudo, K
Citation: Qf. Yang et al., Biallelic inactivation of retinoic acid receptor beta 2 gene by epigeneticchange in breast cancer, AM J PATH, 158(1), 2001, pp. 299-303

Authors: Yang, QF Sakurai, T Shan, L Yu, ZG Yoshimura, G Suzuma, T Tamaki, T Umemura, T Nakamura, M Nakamura, Y Mori, I Kakudo, K
Citation: Qf. Yang et al., Novel polymorphisms of prostate-specific antigen (PSA) gene associated with PSA mRNA expression in breast cancer, J HUM GENET, 45(6), 2000, pp. 363-366

Authors: Suzuma, T Sakurai, T Yoshimura, G Umemura, T Tamaki, T Naito, Y
Citation: T. Suzuma et al., Paclitaxel-induced remission in docetaxel-refractory anthracycline-pretreated metastatic breast cancer, ANTI-CANC D, 11(7), 2000, pp. 569-571

Authors: Yang, QF Sakurai, T Yoshimura, G Takashi, Y Suzuma, T Tamaki, T Umemura, T Nakamura, Y Nakamura, M Utsunomiya, H Mori, I Kakudo, K
Citation: Qf. Yang et al., Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C, ANTICANC R, 20(6B), 2000, pp. 4319-4322

Authors: Yang, QF Sakurai, T Yoshimura, G Shan, L Suzuma, T Tamaki, T Umemura, T Kokawa, Y Nakamura, Y Nakamura, M Tang, WH Utsunomiya, H Mori, I Kakudo, K
Citation: Qf. Yang et al., Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistanceto a series of anticancer drugs in breast carcinoma, BREAST CANC, 61(3), 2000, pp. 211-216

Authors: Yang, QF Sakurai, T Jing, XF Utsunomiya, H Shan, L Nakamura, Y Nakamura, M Oura, S Suzuma, T Yoshimura, G Umemura, T Kokawa, Y Kakudo, K
Citation: Qf. Yang et al., Expression of Bcl-2, but not Bax, correlates with estrogen receptor statusand tumor proliferation in invasive breast carcinoma, PATHOL INT, 49(9), 1999, pp. 775-780

Authors: Yang, QF Shan, L Yoshimura, G Taniguchi, E Suzuma, T Nakamura, Y Nakamura, M Utsunomiya, H Tang, WH Sakurai, T Kakudo, K
Citation: Qf. Yang et al., Thymidine phosphorylase expression in invasive carcinoma: Correlations with clinicopathologic variables and in vitro chemosensitivity to 5-fluorouracil, ANTICANC R, 19(6C), 1999, pp. 5543-5546
Risultati: 1-11 |